Month: November 2013

Audit Look Backs: How Long Is Long Enough?

NCPA supports Rep. Doug Collins (R-Ga.) for his letter to key House committee leaders questioning the wisdom of PBMs being able to audit Part D pharmacies on 10-year-old claims. “If there are bad actors in pharmacy they certainly should be

NCPA, NACDS Poke Holes in PCMA Part D Preferred Network Study

A study paid for by the PBM/mail order lobby, Pharmaceutical Care Management Association, is under fire from community pharmacy groups. NCPA and NACDS pointed out in a letter to CMS that the study makes a number of questionable assumptions in

NCPA Backs the Medicare Efficient Drug Dispensing Act

Last week NCPA sent a formal letter of support to Sen. Ben Cardin (D-Md.) on his bill that would ensure that waste and unnecessary Medicare expenses are minimized in LTC facilities. The legislation, S. 1493, prohibits Part D plan sponsors

Compounding/Pedigree Bill Inching Towards President’s Desk

The Senate is nearing a final vote on long-pending legislation that would protect community pharmacists’ right to compound medicines and also require tracking of prescription drugs as they move through the supply chain. The bill, H.R. 3204, cleared a Senate

Continuing Education Event Presented by HD Smith

HD Smith and St. John’s University College of Pharmacy and Health Science present a continuing education event identifying and preventing prescription fraud and abuse at the pharmacy.  Click on the highlighted information for the registration form or go to the